No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
H.C. Wainwright Initiates Nuvalent(NUVL.US) With Buy Rating, Announces Target Price $110
Express News | Nuvalent, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $110
Jefferies Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $137
Nuvalent Insider Sold Shares Worth $2,338,436, According to a Recent SEC Filing